Results 291 to 300 of about 230,920 (355)

Serious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative

Clinical Pharmacology &Therapeutics, EarlyView.
The U.S. Food and Drug Administration (FDA) used an Active Postmarket Risk Identification and Analysis (ARIA) system to address a safety issue (serious infection) identified during clinical review of an application to market ustekinumab as a treatment for Crohn's disease (CD). FDA used an active‐comparator new‐user cohort design, data from six Sentinel
Joel L. Weissfeld, Geetha S. Iyer, Suna C. Seo, Andrew Giffin, Andrew L. Simon, Sheryl A. Kluberg, Emma R. Hoffman, Jamal T. Jones, Sarah K. Dutcher, Joyce A. Korvick   +9 more
wiley   +1 more source

Comparison of the VITEK REVEAL AST and Accelerate Pheno systems for fast antimicrobial susceptibility testing of gram-negative blood cultures at a large academic health system. [PDF]

J Clin Microbiol
Simmons-Williams C, Soares L, Becker D, Lima A, Rowe L, Uy D, Salazar H, Okeyo Owuor T, Keelara S, Remington R, Carvalhaes C, Silbert S.   +11 more
europepmc   +1 more source

Performance evaluation of early growth isolates for automated and manual broth microdilution antimicrobial-susceptibility testing. [PDF]

J Clin Microbiol
Osborn LJ, Osborn L, Ibarra-Flores I, Garcia M, Perez K, Farhadiayoubloo A, Mitrou M, Costales C, Dien Bard J.   +8 more
europepmc   +1 more source

Enhancing Antimicrobial Susceptibility Testing for Acinetobacter baumannii Using Physiologically Relevant Culture Media and Biofilm Formation Assays. [PDF]

Curr Protoc
Sakyi Opoku NYP, Mishra A, Fletcher H, Nizet V, Abdul-Mutakabbir JC.   +4 more
europepmc   +1 more source

Defining antimicrobial susceptibility testing methods and breakpoints among <i>Achromobacter</i> species. [PDF]

J Clin Microbiol
Harris H, Stambaugh H, Jacobs E, Bhalodi A, Chandrasekaran S, Cole NC, Lu J, Tekle T, Humphries R, Simner PJ.   +9 more
europepmc   +1 more source

Evaluating Antimicrobial Susceptibility Testing Methods for Cefiderocol: A Review and Expert Opinion on Current Practices and Future Directions. [PDF]

Antibiotics (Basel)
Stefani S, Arena F, Principe L, Stracquadanio S, Vismara C, Rossolini GM.   +5 more
europepmc   +1 more source

Erratum for Snyder et al., “Performance of the LifeScale automated rapid phenotypic antimicrobial susceptibility testing on Gram-negative rods directly from positive blood cultures”

James W. Snyder, Nadia Chaudhry, Wesley Hoffmann   +2 more
openalex   +1 more source